Market experts Nipun Mehta and Dilip Bhatdo see no negatives for Sun Pharma if the Ranbaxy deal goes through.
first published: Nov 11, 2014 03:38 pm
A collection of the most-viewed Moneycontrol videos.
JD Vance May Visit Pakistan For Second Round Of Peace Talks With Iran: Reports
Trump Claims Iran N-Sites ‘Obliterated’: ‘Digging Nuclear Dust Won’t Be Easy’
PAN Misuse Alert | How to Check If Someone Opened Bank Accounts in Your Name
Oil prices range bound| Trump renews threat of ‘bombing’ Iran | Nifty set for a cautious start
